Lanza R P, Cooper D K
Bio Hybrid Technologies, Shrewsburg, MA 01545, USA.
Mol Med Today. 1998 Jan;4(1):39-45. doi: 10.1016/S1357-4310(97)80544-8.
The ability to cross species lines will dramatically expand the number of patients and the scope of human diseases that can be treated successfully with transplantation. In addition to whole organs, the transplantation of cells and tissues with specific differentiated functions represents an important conceptual and medical advance. In the USA alone, over 15 million patients suffer from diabetes, over 7 million patients suffer from neurodegenerative diseases, and millions more suffer from liver failure, AIDS, hemophilia and other disorders caused by tissue loss or dysfunction. Clinical trials using animal cells to treat many of these diseases are already under way, and it seems likely that this list will continue to grow as researchers identify new bioactive molecules and expand their understanding of the role different cells play in the human disease process.
跨物种移植的能力将极大地增加可通过移植成功治疗的患者数量和人类疾病范围。除了全器官移植外,具有特定分化功能的细胞和组织移植是一项重要的概念和医学进展。仅在美国,就有超过1500万患者患有糖尿病,超过700万患者患有神经退行性疾病,还有数百万患者患有肝衰竭、艾滋病、血友病以及其他由组织损失或功能障碍引起的疾病。使用动物细胞治疗其中许多疾病的临床试验已经在进行,而且随着研究人员发现新的生物活性分子并加深对不同细胞在人类疾病过程中所起作用的理解,这份疾病清单似乎还会继续增加。